Ask AI about Crossbeta Biosciences
Post your question publicly — other visitors, and whoever manages this page, can answer. It will be visible on this page.
Want to hear about this company again? Follow it and we’ll email you when a new review appears.
AI-generated from reviews on this page. Verify anything important with the company directly.
0 Reviews
Italiano
No reviews
Questions & Answers
No questions yet — be the first to ask.
Sign in to post
Your text is saved — you'll come right back to post.
Don't have an account? Create one
News & Press
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
About Crossbeta Biosciences
Crossbeta Biosciences is a biotech company that has developed an innovative technology to generate stable oligomers for drug discovery and development in disease areas characterized by the presence of misfolded proteins, such as Alzheimer’s, Parkinson’s, Huntington’s disease and ALS. Crossbeta’s unique stable oligomers maintain their biopathological properties for the screening of oligomer-specific therapeutics and for the development of biomarker and diagnostic assays.
- Website
- crossbeta.com
